Literature DB >> 12001903

Mixed warm and cold autoimmune hemolytic anemia: complete recovery after 2 courses of rituximab treatment.

Monica Morselli, Mario Luppi, Leonardo Potenza, Stephanie Tonelli, Daniele Dini, Giovanna Leonardi, Amedea Donelli, Franco Narni, Giuseppe Torelli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12001903     DOI: 10.1182/blood-2002-01-0018

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

1.  A patient with mixed type Evans syndrome: efficacy of rituximab treatment.

Authors:  Chi Young Park; Choon Hae Chung
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

Review 2.  Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review.

Authors:  Peter Valent; Klaus Lechner
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

3.  Good outcome after rituximab treatment for a mixed warm and cold autoimmune haemolytic anaemia.

Authors:  Brigitte Granel; Pascal Rossi; Fanny Bernard; Isabelle Dettori; Regis Costello; Anne Laurence Demoux; Denis Bagneres; Pierre Lafforgue; Yves Frances
Journal:  BMJ Case Rep       Date:  2009-03-06

Review 4.  Rituximab in the treatment of autoimmune haemolytic anaemia.

Authors:  Chaturaka Rodrigo; Senaka Rajapakse; Lallindra Gooneratne
Journal:  Br J Clin Pharmacol       Date:  2015-05       Impact factor: 4.335

5.  Severe refractory autoimmune hemolytic anemia with both warm and cold autoantibodies that responded completely to a single cycle of rituximab: a case report.

Authors:  Shilpi Gupta; Anita Szerszen; Fadi Nakhl; Seema Varma; Aaron Gottesman; Frank Forte; Meekoo Dhar
Journal:  J Med Case Rep       Date:  2011-04-19

6.  Rare presentation of mixed autoimmune hemolytic anemia in children: Report of 2 cases.

Authors:  Preeti Rai; Geetika Sharma; Deeksha Singh; Jyoti Garg
Journal:  J Lab Physicians       Date:  2017 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.